Peripheral artery disease: a micro-RNA-related condition?

Area of Science:

• Cardiovascular research
• Molecular biology
• Biomarker discovery

Background:

• Peripheral artery disease (PAD) is a significant cause of cardiovascular morbidity and mortality, characterized by diffuse atherosclerosis.
• Understanding the molecular mechanisms of PAD is crucial for improving patient outcomes.
• MicroRNAs (miRNAs), small noncoding RNAs, exhibit disease-specific expression patterns and are stable in circulation.

Purpose of the Study:

• To review the current literature on the role of specific microRNAs (miRNAs) in the context of peripheral artery disease (PAD).
• To explore the potential of miRNAs in regulating angiogenesis and vascular integrity in PAD.
• To highlight the utility of miRNAs as minimally invasive diagnostic biomarkers and for risk stratification in PAD.

Main Methods:

• Literature review of studies investigating microRNA regulation in peripheral artery disease.
• Analysis of research focusing on miRNA roles in angiogenesis and vascular maintenance.
• Synthesis of findings related to miRNA expression in PAD for diagnostic and prognostic potential.

Main Results:

• Specific microRNAs (miRNAs) are implicated in the molecular pathology of peripheral artery disease (PAD).
• miRNA dysregulation affects key processes such as angiogenesis and vascular integrity in PAD.
• Circulating miRNAs present a promising avenue for minimally invasive diagnosis and risk stratification in PAD.

Conclusions:

• MicroRNAs (miRNAs) are emerging as critical regulators in peripheral artery disease (PAD) pathogenesis.
• miRNAs hold significant potential as novel, minimally invasive biomarkers for PAD diagnosis and risk assessment.
• Further research into miRNA-based diagnostics and therapeutics could personalize PAD treatment strategies.